Literature DB >> 1445231

Tissue distribution of mRNA for heparin-binding epidermal growth factor.

T J Vaughan1, J C Pascall, K D Brown.   

Abstract

Heparin-binding epidermal growth factor (HB-EGF) is a recently identified member of the EGF family. Mature HB-EGF is processed from a larger transmembrane precursor which can itself act as a cell-surface receptor for the internalization of diphtheria toxin into eukaryotic cells. However, to date there is no information available on the distribution of HB-EGF in mammalian tissues. We have therefore used reverse-transcription PCR to analyse the expression of HB-EGF mRNA in a wide range of tissues. HB-EGF transcripts were detected in RNA isolated from 15 of the 22 tissues obtained from adult pigs, which is consistent with the ability of diphtheria toxin to affect many body tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445231      PMCID: PMC1133061          DOI: 10.1042/bj2870681

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

Review 1.  Diphtheria toxin: mode of action and structure.

Authors:  R J Collier
Journal:  Bacteriol Rev       Date:  1975-03

2.  Transforming growth factor alpha in developing rats.

Authors:  P I Brown; R Lam; J Lakshmanan; D A Fisher
Journal:  Am J Physiol       Date:  1990-08

3.  Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor.

Authors:  J G Naglich; J E Metherall; D W Russell; L Eidels
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

4.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF.

Authors:  S Higashiyama; J A Abraham; J Miller; J C Fiddes; M Klagsbrun
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

Review 5.  The type 1 (EGFR-related) family of growth factor receptors and their ligands.

Authors:  S A Prigent; N R Lemoine
Journal:  Prog Growth Factor Res       Date:  1992

Review 6.  Epidermal growth factor and the nervous system.

Authors:  C R Plata-Salamán
Journal:  Peptides       Date:  1991 May-Jun       Impact factor: 3.750

7.  Expression of epidermal growth factor and its mRNA in pig kidney, pancreas and other tissues.

Authors:  T J Vaughan; J C Pascall; P S James; K D Brown
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

8.  Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues.

Authors:  R Fukuyama; N Shimizu
Journal:  J Exp Zool       Date:  1991-06

9.  Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences.

Authors:  A J Blasband; K T Rogers; X R Chen; J C Azizkhan; D C Lee
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

10.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity.

Authors:  G D Plowman; J M Green; V L McDonald; M G Neubauer; C M Disteche; G J Todaro; M Shoyab
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

View more
  10 in total

1.  Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma.

Authors:  Y Ito; S Higashiyama; T Takeda; Y Yamamoto; K I Wakasa; N Matsuura
Journal:  Int J Pancreatol       Date:  2001

2.  The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha.

Authors:  Katya Chobotova; Mary-Elizabeth Muchmore; Janet Carver; Hyung-J Yoo; Sanjiv Manek; William J Gullick; David H Barlow; Helen J Mardon
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

3.  Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing.

Authors:  Andrei Radulescu; Hong-Yi Zhang; Chun-Liang Chen; Yan Chen; Yu Zhou; Xiaoyi Yu; Iyore Otabor; Jacob K Olson; Gail E Besner
Journal:  J Surg Res       Date:  2010-09-08       Impact factor: 2.192

Review 4.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.

Authors:  J D Liao; N V Adsay; F Khannani; D Grignon; A Thakur; F H Sarkar
Journal:  Histol Histopathol       Date:  2007-06       Impact factor: 2.303

5.  Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen-activated protein kinase cascades.

Authors:  P D Ellis; K M Hadfield; J C Pascall; K D Brown
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

6.  Immunohistochemical localization of heparin-binding epidermal growth factor-like growth factor in normal skin and skin cancers.

Authors:  M T Downing; D R Brigstock; M H Luquette; M Crissman-Combs; G E Besner
Journal:  Histochem J       Date:  1997-10

7.  Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.

Authors:  D Aviezer; A Yayon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

8.  Characterization of pancreatic lesions from MT-tgf alpha, Ela-myc and MT-tgf alpha/Ela-myc single and double transgenic mice.

Authors:  Dezhong Joshua Liao; Yong Wang; Jiusheng Wu; Nazmi Volkan Adsay; David Grignon; Fayyaz Khanani; Fazlul H Sarkar
Journal:  J Carcinog       Date:  2006-07-05

9.  Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway.

Authors:  Hong Lian; Yuanwu Ma; Juan Feng; Wei Dong; Qing Yang; Dan Lu; Lianfeng Zhang
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells.

Authors:  S Ushiro; M Ono; H Izumi; K Kohno; N Taniguchi; S Higashiyama; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1996-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.